Schedule of stock option assumptions


Schedule of stock option grant activity	Number			Weighted Average Exercise Price			Weighted Average Remaining Life
Outstanding at September 30, 2025		7,304,992		$	11.50			4.79
Granted		300,000			0.01			—
Expired		—			—			—
Exercised		(495,509	)		(11.50	)		(4.79	)
Outstanding at December 31, 2025		7,109,483			11.02			4.56
Granted		1,333,333			9.00			5.00
Expired		—			—			—
Exercised		(46,747	)		(11.50	)		(4.56	)
Outstanding at March 31, 2026		8,396,069		$	10.69			4.41

At March 31, 2026 and September 30, 2025, the intrinsic value of the warrants was $1,419,000 and $0, respectively.

The assumptions used in Monte Carlo Simulation model related to the February 26, 2026 1,333,333 warrants issuance are set forth in the table immediately below:

Schedule of stock option assumptions
	February 26, 2026
Stock Price	$	7.96
Exercise Price	$	9.00
Volatility		73.0	%
Risk free rate of return		3.54	%
Term to maturity (years)		5.00
Term to financing (years)		2.50

Schedule of stock option grant activity

Schedule of Black-Scholes model
	January 2, 2026 - March 12, 2026			August 6, 2025 - September 2, 2025
Exercise price		$ 9.26 - 7.47			$ 3.27 - 9.09
Risk-free interest rate		3.74 - 3.84	%		3.58 -3.91	%
Volatility		73.0 - 86.3	%		101.4 - 114.4	%
Expected life (years)		4 - 4.5			3.19 - 5.00
Dividend yield		0	%		0	%

The following is an analysis of the stock option grant activity:


	Number			Weighted Average Exercise Price			Weighted Average Remaining Life
Outstanding at September 30, 2025		—		$	—			—
Granted		6,850,000			7.42			5.23
Expired		—			—			—
Exercised		—			—			—
Outstanding at December 31, 2025		6,850,000			7.42			5.23
Granted		1,000,000			8.37			5.00
Expired		—			—			—
Forfeited		(3,600,000	)		(8.04	)		(4.38	)
Outstanding at March 31, 2026		4,250,000			7.75			5.85

Schedule of Black-Scholes model	June 30, 2025
Exercise price		3.27 – 9.09
Risk-free interest rate		3.58 – 3.91	%
Volatility		101.4 – 114.4	%
Expected life (years)		3.19-5.00
Dividend yield	$	0	%

The following is an analysis of the stock option grant activity:

Schedule of stock option grant activity
	Number		Weighted Average Exercise Price		Weighted Average Remaining Life
Outstanding at September 30, 2024		—	$	—		—
Granted		6,850,000		7.42		5.23
Expired		—		—		—
Exercised		—		—		—
Outstanding at September 30, 2025		6,850,000	$	7.42		5.23
Exercisable at September 30, 2025		—

Schedule of recognize the remaining total stock-based compensation


Year	Amount
2026	$	2,450,154
2027		4,900,308
2028		4,900,308
2029		3,703,652
2030		265,026
Total	$	16,219,448


Year	Amount
Remainder of 2025	$	2,009,847
2026		8,039,388
2027		8,039,388
2028		8,039,388
2029		5,000,388
Total	$	31,128,519